Department of Radiation Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, China , caocn@zjcc.org.cn
Abstract: (638 Views)
Nasopharyngeal carcinoma (NPC) is a radiotherapy-sensitive tumor, but local recurrence still exists in part of the patients after receiving radiotherapy. The location of local recurrence of NPC is usually “in-field” and cases of parotid and mastoid recurrences have been reported. We report a fifty-nine-year-old female patient who presented with maxillary sinus anterior wall recurrence seven months after intensity-modulated radiotherapy (IMRT). Magnetic resonance imaging (MRI) showed a soft tissue mass in the anterior wall of the right maxillary sinus and the recurrence of NPC was confirmed by histopathology after biopsy. To date, the patient is alive with disease without distant metastasis. To our knowledge, this is the first report of maxillary Sinus anterior wall recurrence after IMRT for NPC.
1. Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J (2019) Nasopharyngeal carcinoma. Lancet, 394(10192): 64-80. [DOI:10.1016/S0140-6736(19)30956-0]
2. Tang LL, Chen YP, Chen CB, Chen MY, Chen NY, Chen XZ, et al. (2021) The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma. Cancer Commun (Lond), 41(11): 1195-1227. [DOI:10.1002/cac2.12218]
3. Sun XS, Li XY, Chen QY, Tang LQ, Mai HQ (2019) Future of Radiotherapy in Nasopharyngeal Carcinoma. Br J Radiol, 92(1102): 20190209. [DOI:10.1259/bjr.20190209]
4. Kong L, Wang L, Shen C, Hu C, Wang L, Lu JJ (2016) Salvage Intensity-Modulated Radiation Therapy (IMRT) for Locally Recurrent Nasopharyngeal Cancer after Definitive IMRT: A Novel Scenario of the Modern Era. Sci Rep, 6: 32883. [DOI:10.1038/srep32883]
5. Dawson LA, Anzai Y, Marsh L, Martel MK, Paulino A, Ship JA, et al. (2000) Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys, 46(5): 1117-1126. [DOI:10.1016/S0360-3016(99)00550-7]
6. Zhang X, Luo J, Gao L, Xu G (2011) Mastoid recurrence after radiotherapy for nasopharyngeal carcinoma: two case studies. Head Neck, 33(10): 1535-1538. [DOI:10.1002/hed.21391]
7. Autorino R, Miccichè F, Dinapoli N, Bussu F, Balducci M, Mattiucci GC, et al. (2012) Recurrence in region of spared parotid gland in patient receiving definitive intensity-modulated radiotherapy for nasopharyngeal cancer: a case report. Acta Oncol, 51(8): 1095-1099. [DOI:10.3109/0284186X.2012.673735]
8. Cao CN, Luo JW, Gao L, Yi JL, Huang XD, Wang K, et al. (2013) Clinical characteristics and patterns of failure in the parotid region after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Oral Oncol, 49(6): 611-614. [DOI:10.1016/j.oraloncology.2013.02.001]
9. Chow JCH, Tam AHP, Cheung KM, Lee VHF, Chiang CL, Tong M, et al. (2020) Second primary cancer after intensity-modulated radiotherapy for nasopharyngeal carcinoma: A territory-wide study by HKNPCSG. Oral Oncology, 111. [DOI:10.1016/j.oraloncology.2020.105012]
10. Zhang LL, Li GH, Li YY, Qi ZY, Lin AH, Sun Y (2019) Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big-Data Intelligence Platform-Based Analysis of 6,377 Long-term Survivors from an Endemic Area Treated with Intensity-Modulated Radiation Therapy during 2003-2013. Cancer Res Treat, 51(3): 982-991. [DOI:10.4143/crt.2018.298]
11. Ng WT, Lee MC, Chang AT, Chan OS, Chan LL, Cheung FY, et al. (2014) The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRT. Oral Oncol, 50(5): 506-512. [DOI:10.1016/j.oraloncology.2014.01.017]
12. Ng WT, Lee MC, Hung WM, Choi CW, Lee KC, Chan OS, et al. (2011) Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 79(2): 420-428. [DOI:10.1016/j.ijrobp.2009.11.024]
13. Lee AW, Ng WT, Pan JJ, Poh SS, Ahn YC, AlHussain H, et al. (2018) International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiother Oncol, 126(1): 25-36. [DOI:10.1016/j.radonc.2017.10.032]
14. Ng WT, Chow JCH, Beitler JJ, Corry J, Mendenhall W, Lee AWM, et al. (2022) Current Radiotherapy Considerations for Nasopharyngeal Carcinoma. Cancers (Basel), 14(23). [DOI:10.3390/cancers14235773]
15. Chan JY, Wong ST, Wei WI (2014) Whole-organ histopathological study of recurrent nasopharyngeal carcinoma. Laryngoscope, 124(2): 446-450. [DOI:10.1002/lary.24218]
16. Wang HZ, Cao CN, Luo JW, Yi JL, Huang XD, Zhang SP, et al. (2016) High-risk factors of parotid lymph node metastasis in nasopharyngeal carcinoma: a case-control study. Radiat Oncol, 11(1): 113. [DOI:10.1186/s13014-016-0691-x]
Fang Y, Wang L, Chen X, Cao C. Maxillary sinus anterior wall recurrence after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Res 2024; 22 (3) :803-805 URL: http://ijrr.com/article-1-5666-en.html